Saitama Medical University have just concluded Entrusted Research Contract with CyberHeart Inc.(California,USA)
Correspondence Researcher : Dr Kazuo Matsumoto, professor of Cardiac Internal Medicine, International Medical Center, Saitama Medical University,
and
Dr Takushi Dokiya, professor of Radiation Oncology, International Medical Center, Saitama Medical University,
Subject: End to End Test for Electrical Isolation of the Pulmonary Vein using Radiosurgical Ablation.
Term: till March 2011.
Comment from Patrick Maguire,President and CEO, CyberHeart Inc.(California,USA)
‘ We are very excited about this opportunity for establishing new approach in cardiac treatment.We believe Saitama Medical University is well positioned for the study with excellent resorces and capability. I am glad to see our technology is going to be realized and to be further investigated for the new era.’
CyberHeart Inc. is a privately owned medical device company,which designs and manufacturers radiosurgical ablation system. This system intends to treat the patients suffering from atrial fibrillation with unique approach utilizing radiation as a non-invasive treatment method.